Catalyst Wire Dossier Catalyst Wire Dossier

RBD7022

RBD7022 · Suzhou Ribo Life Science Co. Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RBD7022, covering 2025-05-01 to 2025-05-01. Get the full timeline:

Most recent: Clinical Trial Update: A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD7022 [Phase 1]

See pricing